Please assess the completion status of the following clinical trial:

Trial Title: A Lifestyle Physical Activity Intervention for Older Sedentary Women

Study Design Characteristics:
- Allocation: RANDOMIZED
- Intervention Model: PARALLEL
- Observational Model: None
- Primary Purpose: PREVENTION
- Time Perspective: None
- Masking: SINGLE
- Phase: None
- Number of Arms: 2.0

Eligibility Criteria:
Inclusion Criteria:~* women \> 60 years of age who are Senior Health clinic patients~* health care provider's approval to participate~* ability to speak/read English~* access to a telephone~Exclusion Criteria:~* report participation in a regular physical activity program~* report an unresolved acute illness, such as pneumonia or flu~* fail screening for capacity to provide informed consent~* fail a simple functional screen or are currently nonambulatory~* are unable to complete activities of daily living~* have uncorrectable severe hearing or vision deficits~* have a history of falls in the past 3 months~* have other unforeseen pathology that precludes safe participation

- Gender: FEMALE
- Minimum Age: 60 Years
- Maximum Age: None
- Healthy Volunteers: t

Study Arms:
- Lifestyle Physical Activity Intervention (Type: EXPERIMENTAL): the women will be randomized to either the LPA Intervention or Information/Attention Comparison groups using a permuted block randomization scheme. Participants in both groups will be followed longitudinally with repeated assessments of LPA (accelerometer \& LPA diary), stage of change, and self-efficacy at baseline and 3 and 6 months; and functional health and well-being (SF36) at baseline and 6 months.
- Information/Attention Comparison (Type: ACTIVE_COMPARATOR): the women will be randomized to either the LPA Intervention or Information/Attention Comparison groups using a permuted block randomization scheme. Participants in both groups will be followed longitudinally with repeated assessments of LPA (accelerometer \& LPA diary), stage of change, and self-efficacy at baseline and 3 and 6 months; and functional health and well-being (SF36) at baseline and 6 months.

Based on this trial design, predict the completion outcome and termination type (if applicable).